Nalaganje...
Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
There are a wide range of therapies for metastatic colorectal cancer (CRC) available, but outcomes remain suboptimal. Learning the role of the immune system in cancer development and progression led to advances in the treatment over the last decade. While the field is rapidly evolving, PD-1, and PD-...
Shranjeno v:
| izdano v: | Front Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527887/ https://ncbi.nlm.nih.gov/pubmed/31139574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00396 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|